Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

11
Number of overlapping holdings
26.8%
% of GNOM's 41 holdings also in FBT
36.7%
% of FBT's 31 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus FBT)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in GNOM |
Weight in FBT |
Overlap | |
---|---|---|---|---|
ULTRAGENYX PHARMACEUTICAL IN | 3.8% | 3.8% | 3.8% | |
QIAGEN NV | 3.6% | 3.6% | 3.6% | |
BIOMARIN PHARMACEUTICAL INC | 3.5% | 3.6% | 3.5% | |
BIONTECH SE SPONSORED ADR | 3.3% | 3.6% | 3.3% | |
ALNYLAM PHARMACEUTICALS INC | 3.3% | 3.3% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to FBT
ENI SPA-SPONSORED ADR | 7.5% | |
CRISPR THERAPEUTICS AG | 5.8% | |
NATERA INC | 4.4% | |
INTELLIA THERAPEUTICS, INC. | 4.0% | |
ARROWHEAD PHARMACEUTICALS, INC. | 3.9% | |
AGILENT TECHNOLOGIES INC | 3.9% | |
10X GENOMICS INC CLASS A | 3.8% | |
GENSCRIPT BIOTECH CORPORATION | 3.7% | |
PACIFIC BIOSCIENCES OF CALIF | 3.7% | |
BEAM THERAPEUTICS, INC. | 3.6% |
GNOM Underweight Relative to FBT
GRIFOLS SA-ADR | -3.9% | |
IQVIA HOLDINGS INC | -3.7% | |
IONIS PHARMACEUTICALS, INC. | -3.5% | |
GENMAB A/S SPONSORED ADR | -3.5% | |
METTLER-TOLEDO INTERNATIONAL | -3.5% | |
CHARLES RIVER LABORATORIES | -3.5% | |
ARGENX SE ADR | -3.4% | |
AGIOS PHARMACEUTICALS INC | -3.4% | |
UNITED THERAPEUTICS CORP | -3.4% | |
EXELIXIS INC | -3.4% |